METTL9 and cancer: Thus, our results suggest that METTL9-mediated 1-methylhistidine modification on the mitochondrial component is associated with the activity of mitochondrial Complex I. Dysregulation of mitochondria causes dynamic changes in intracellular energetic production and metabolic profiling, and thus supports the aggressiveness of cancer cells, i.e., cancer metastasis [18,19].